A pharmacy that receives a DEA order to show cause has 30 days to request a hearing before an administrative law judge, or the right to contest the action is waived by default. What happens inside that hearing, not the order itself, decides whether your pharmacy keeps its registration to handle controlled substances. The process runs on strict deadlines, a shifting burden of proof, and a five-factor public interest test most pharmacists have never had to prepare for.
The Order to Show Cause and the Hearing Request Deadline
Before DEA revokes, suspends, or denies a registration under 21 U.S.C. 824(a), it must serve an order to show cause identifying the specific grounds under 21 CFR 1301.37. Under 21 CFR 1301.43, the pharmacy must file a written hearing request and an answer to the allegations within 30 days of receiving the order, or the right to a hearing is waived by default absent good cause. Responding to a DEA Order to Show Cause covers the notice-stage steps that precede the hearing itself.
Immediate Suspension Orders and the Imminent Danger Standard
DEA does not always wait for a hearing to act. Under 21 U.S.C. 824(d), the agency may issue an immediate suspension order without a prior hearing when it finds an imminent danger to the public health or safety, defined by statute as a substantial likelihood that death, serious bodily harm, or diversion will occur before a hearing could be completed. The suspension takes effect the day it is served, and DEA's Office of Administrative Law Judges prioritizes the resulting hearing over standard show cause dockets.
The Administrative Law Judge Hearing Process
Hearings on a DEA registration proceed under 21 CFR Part 1316, Subpart D. Once a hearing is requested, an administrative law judge is assigned and orders both DEA and the pharmacy to file prehearing statements identifying the disputed issues, witnesses, and documents each side intends to introduce. A prehearing conference and discovery typically follow, before the judge sets a hearing date. The hearing itself resembles a trial without a jury: witnesses testify under oath, exhibits go into the record, and each side may cross-examine the other's witnesses. Post-hearing briefs follow, and the judge issues a recommended decision. Either party may file exceptions within 20 days; the record then goes to the DEA Administrator, who issues a final order published in the Federal Register. A registrant dissatisfied with that order has 30 days under 21 U.S.C. 877 to petition a United States Court of Appeals.
Burden of Proof and the Public Interest Factors
Under 21 CFR 1301.44, DEA carries the burden of proving that the requirements for revocation or suspension are satisfied, not the pharmacy. DEA must first establish a prima facie case that continued registration is inconsistent with the public interest before the burden shifts to the pharmacy to show why its registration should be retained. That public interest determination under 21 U.S.C. 823(g)(1) turns on five factors: the recommendation of the state licensing board, the pharmacy's experience dispensing controlled substances, its conviction record under state or federal controlled substance laws, its compliance with applicable controlled substance laws, and any other conduct that may threaten public health and safety. DEA Registration Denials and the Public Interest Factors examines how the agency weighs these five factors case by case.
Building the Evidentiary Record
Because DEA's case typically rests on the pharmacy's own records, the strength of the defense often depends on what those files show before the hearing starts. Dispensing logs, prescriber verification notes, inventory reconciliation results, and suspicious order monitoring documentation are the records DEA auditors flag first, and the records a pharmacy needs organized before the judge. DEA Recordkeeping: The Audit-Ready Controlled Substance File covers what a defensible controlled substance file looks like before an audit becomes an order to show cause.
DEA carries the burden of proof at the hearing, but a pharmacy that shows up without its own record has already conceded the public interest factors.
Why Early Legal Counsel Is Critical
It is critical that pharmacies promptly retain experienced healthcare defense counsel upon receiving a DEA order to show cause, an immediate suspension order, or any other DEA inquiry. Early legal intervention can protect the pharmacy's rights, structure the prehearing statement and evidentiary record before deadlines close, avoid testimony that concedes points the record cannot recover, and preserve the defenses available at the hearing and on appeal.
How Health Law Alliance Can Help
Health Law Alliance represents pharmacies in DEA administrative hearings arising from orders to show cause and immediate suspension orders, as part of the firm's DEA defense practice. The firm builds the prehearing statement and the evidentiary record from the day the order is served, not the week before the hearing. If your pharmacy has received a DEA order to show cause or an immediate suspension order, contact us for a free, confidential consultation.
